[Federal Register Volume 76, Number 198 (Thursday, October 13, 2011)]
[Notices]
[Page 63623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-26501]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Environmental 
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

Times and Dates

    8:30 a.m.-4:30 p.m., November 3, 2011.
    8:30 a.m.-12:30 p.m., November 4, 2011.
    Place: CDC, 4770 Buford Highway, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 75 people.
    Purpose: The Secretary, Department of Health and Human Services 
(HHS) and by delegation, the Director, CDC and Administrator, NCEH/
ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 
(42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) 
Conduct, encourage, cooperate with, and assist other appropriate public 
authorities, scientific institutions, and scientists in the conduct of 
research, investigations, experiments, demonstrations, and studies 
relating to the causes, diagnosis, treatment, control, and prevention 
of physical and mental diseases and other impairments; (2) assist 
states and their political subdivisions in the prevention of infectious 
diseases and other preventable conditions and in the promotion of 
health and well being; and (3) train state and local personnel in 
health work. The BSC, NCEH/ATSDR provides advice and guidance to the 
Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the 
Director, NCEH/ATSDR, regarding program goals, objectives, strategies, 
and priorities in fulfillment of the agency's mission to protect and 
promote people's health. The board provides advice and guidance that 
will assist NCEH/ATSDR in ensuring scientific quality, timeliness, 
utility, and dissemination of results. The board also provides guidance 
to help NCEH/ATSDR work more efficiently and effectively with its 
various constituents and to fulfill its mission in protecting America's 
health.
    Matters To Be Discussed: The agenda items for the BSC Meeting on 
November 3-4, 2011, will include NCEH/ATSDR Office of the Director 
updates: ATSDR and NCEH Reorganization; update on Asthma, Lead and 
Healthy Homes Program; presentation on public health prioritization at 
ATSDR; update on the Nutritional Biomarker Report: transfat analysis; 
update on ATSDR Science Symposium; update on Camp LeJeune; update on 
Environmental Health Tracking; presentation on hydraulic fracking; 
global health updates: indoor air pollution and health and lead in 
Nigeria.
    Agenda items are subject to change as priorities dictate.

SUPPLEMENTARY INFORMATION: The public comment period is scheduled on 
Thursday, November 3, 2011 from 4:15 p.m. until 4:25 p.m., and Friday, 
November 4, 2011, from 12:15 p.m. until 12:25 p.m.
    Contact Person for More Information: Sandra Malcom, Committee 
Management Specialist, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F-61, 
Chamblee, Georgia 30345; Telephone: (770) 488-0575; Fax: (770) 488-
3377; E-mail: [email protected]. The deadline for notification of 
attendance is October 27, 2011.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention, and the Agency for 
Toxic Substances and Disease Registry.

    Dated: October 6, 2011.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 2011-26501 Filed 10-12-11; 8:45 am]
BILLING CODE 4163-18-P